QGEN

MKT CAP:$8B

Qiagen N.V.

Market Cap

$8B

Healthcare·Medical - Diagnostics & Research·🇳🇱 Netherlands·NYSE

Healthcare·Medical·🇳🇱·NYSE

Stock Price

$38.11-$9.46 (-19.89%)

Apr 23, 2026

Company Details

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primar...

CEO

Thierry Bernard

IPO Date

Jun 28, 1996

Website

www.qiagen.com

Key Metrics TTM

Revenue

$2.1B

+5.7% YoY

Net Income

$425M

EPS (Diluted)

$1.97

Free Cash Flow

$453M

Revenue / Share

$10.06

Gross Margin

61.8%

Operating Margin

24.9%

Net Margin

20.3%

FCF Margin

21.7%

P/S

3.8x

P/E

18.5x

Earnings Reports

Q1 2026

May 6, 2026

PENDING

FY 2025

Mar 19, 2026

$2.1B+5.7%EPS $2.04

Q4 2025

Mar 19, 2026

$540M+3.7%EPS $0.52

Q3 2025

Nov 5, 2025

$533M+6.1%EPS $0.60

Q2 2025

Aug 21, 2025

$534M+7.5%EPS $0.44

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$628M	$415M	$207M
Q2 22	$516M	$331M	$122M
Q3 22	$500M	$321M	$98M
Q4 22	$498M	$318M	$105M
Q1 23	$485M	$307M	$97M
Q2 23	$495M	$312M	$105M
Q3 23	$476M	$298M	$97M
Q4 23	$509M	$316M	$111M
Q1 24	$459M	$291M	$95M
Q2 24	$496M	$35M	-$228M
Q3 24	$502M	$308M	$112M
Q4 24	$521M	$333M	$119M
Q1 25	$483M	$309M	$115M
Q2 25	$534M	$334M	$122M
Q3 25	$533M	$331M	$129M
Q4 25	$540M	$317M	$154M

Valuation

Quarter	P/S	P/E
Q1 22	4.8x	20.6x
Q2 22	4.8x	21.0x
Q3 22	4.2x	20.2x
Q4 22	5.2x	26.5x
Q1 23	5.1x	28.8x
Q2 23	5.1x	29.9x
Q3 23	4.6x	26.9x
Q4 23	5.2x	29.9x
Q1 24	4.8x	27.4x
Q2 24	4.5x	120.2x
Q3 24	5.0x	106.5x
Q4 24	4.8x	113.0x
Q1 25	4.4x	93.6x
Q2 25	5.1x	27.9x
Q3 25	4.6x	23.5x
Q4 25	4.7x	23.3x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	$207M	$169M
Q2 22	$172M	$134M
Q3 22	$212M	$185M
Q4 22	$124M	$78M
Q1 23	$72M	$34M
Q2 23	$111M	$80M
Q3 23	$125M	$84M
Q4 23	$151M	$99M
Q1 24	$133M	$95M
Q2 24	$167M	$128M
Q3 24	$182M	$138M
Q4 24	$192M	$142M
Q1 25	$140M	$96M
Q2 25	$161M	$121M
Q3 25	$165M	$119M
Q4 25	$188M	$117M

Capital Expenditures

Quarter	CapEx
Q1 22	$38M
Q2 22	$38M
Q3 22	$27M
Q4 22	$47M
Q1 23	$38M
Q2 23	$31M
Q3 23	$41M
Q4 23	$52M
Q1 24	$38M
Q2 24	$39M
Q3 24	$44M
Q4 24	$50M
Q1 25	$44M
Q2 25	$41M
Q3 25	$46M
Q4 25	$71M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+10.8%	+4.4%
Q2 22	-9.1%	-3.1%
Q3 22	-6.6%	-0.2%
Q4 22	-14.5%	-3.9%
Q1 23	-22.8%	-7.7%
Q2 23	-4.0%	-1.0%
Q3 23	-4.8%	-5.8%
Q4 23	+2.2%	+1.3%
Q1 24	-5.5%	-6.4%
Q2 24	+0.3%	+86.1%
Q3 24	+5.5%	+2.9%
Q4 24	+2.4%	+0.9%
Q1 25	+5.4%	+1.2%
Q2 25	+7.5%	-43.2%
Q3 25	+6.1%	+3.5%
Q4 25	+3.7%	-3.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$12M	1.9%
Q2 22	$11M	2.2%
Q3 22	$13M	2.5%
Q4 22	$14M	2.7%
Q1 23	$14M	2.9%
Q2 23	$8M	1.6%
Q3 23	$13M	2.7%
Q4 23	$12M	2.4%
Q1 24	$14M	3.0%
Q2 24	$10M	2.0%
Q3 24	$9M	1.8%
Q4 24	$11M	2.1%
Q1 25	$12M	2.6%
Q2 25	$11M	2.0%
Q3 25	$11M	2.0%
Q4 25	$17M	3.1%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 22	$46M	$34M	$119M	—
Q2 22	$50M	$33M	$119M	—
Q3 22	$49M	$31M	$115M	—
Q4 22	$45M	$32M	$122M	—
Q1 23	$55M	$33M	$115M	—
Q2 23	$50M	$29M	$116M	—
Q3 23	$48M	$29M	$111M	—
Q4 23	$46M	$28M	$117M	—
Q1 24	$51M	$28M	$111M	—
Q2 24	$49M	$29M	$115M	—
Q3 24	$44M	$29M	$111M	—
Q4 24	$49M	$28M	$114M	—
Q1 25	$44M	$32M	$106M	—
Q2 25	$48M	$31M	$118M	—
Q3 25	$49M	$30M	$113M	—
Q4 25	$47M	—	—	$154M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$771M	$459M	$1.2B
Q2 22	$707M	$604M	$1.3B
Q3 22	$1.3B	$615M	$1.9B
Q4 22	$731M	$688M	$1.4B
Q1 23	$359M	$928M	$1.3B
Q2 23	$610M	$722M	$1.3B
Q3 23	$580M	$436M	$1.0B
Q4 23	$668M	$390M	$1.1B
Q1 24	$514M	$379M	$893M
Q2 24	$534M	$357M	$890M
Q3 24	$973M	$507M	$1.5B
Q4 24	$664M	$489M	$1.2B
Q1 25	$639M	$325M	$963M
Q2 25	$734M	$220M	$954M
Q3 25	$1.4B	$334M	$1.7B
Q4 25	$839M	$260M	$1.1B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	230M	-0.7%	-0.9%
Q2 22	230M	-0.1%	-0.9%
Q3 22	230M	+0.1%	-0.9%
Q4 22	223M	-2.9%	-3.6%
Q1 23	224M	+0.1%	-2.8%
Q2 23	224M	-0.0%	-2.8%
Q3 23	224M	+0.0%	-2.8%
Q4 23	224M	+0.1%	+0.2%
Q1 24	227M	+1.2%	+1.3%
Q2 24	222M	-2.0%	-0.7%
Q3 24	224M	+0.9%	+0.2%
Q4 24	218M	-2.7%	-2.6%
Q1 25	220M	+1.0%	-2.8%
Q2 25	218M	-0.9%	-1.7%
Q3 25	218M	+0.1%	-2.5%
Q4 25	208M	-4.9%	-4.7%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$104.2K	6K
Q2 22	$85.5K	6K
Q3 22	$82.9K	6K
Q4 22	$80.3K	6K
Q1 23	$78.3K	6K
Q2 23	$79.8K	6K
Q3 23	$76.8K	6K
Q4 23	$84.9K	6K
Q1 24	$76.5K	6K
Q2 24	$82.7K	6K
Q3 24	$83.6K	6K
Q4 24	$91.4K	6K
Q1 25	$84.8K	6K
Q2 25	$93.6K	6K
Q3 25	$93.4K	6K
Q4 25	$94.8K	6K

Revenue / Employee